Fig. 4
From: Insights into the pharmaceutical properties of green fabricated Iron oxide nanoparticles
Antiviral activity of A. cepa extract and Fe3O4-NPs. The upper panel represented the viability of MDCK cells after being treated with A. cepa extract and Fe3O4-NPs. The middle panel represented the ability of A. cepa extract and Fe3O4-NPs to inhibit neuraminidase enzyme. The concentration of Fe3O4-NPs was (25–100) µg/ml. Data were represented as mean ± SD of 3 independent experiments. The lower panel represented ROS generation assay using DCFH-AD. (A) Control untreated cells. (B) Cells were infected with the virus. (C) Cells infected with the virus in the presence of A. cepa extract. (D) Cells infected with the virus in the presence of Fe3O4-NPs at 50 µg/ml concentrations.
